After a no-good, very bad year, Axovant reshuffles the deck
Bad news has piled up at Axovant, including the poor showing of its Parkinsons/Lewy body drug, and now the CEO David Hung is out after a mere 10 months on the job.
Axovant hires ex-Medivation CEO as it nears Phase 3 Alzheimer’s readout
Axovant founder and CEO Vivek Ramaswamy has stepped back from the top job, passing the reins to David Hung as the company nears a Phase 3 data readout for its lead Alzheimer's drug candidate.
presented by
How to Optimize Your Phlebotomy Setup for Efficient Patient Care
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.